Items where authors include "Saunders, MP"

Export as [feed] Atom [feed] RSS
Number of items: 8.

Article

Sekhar, H, Kochhar, R, Carrington, B et al. (7 more authors) (2020) Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study. BMC Cancer, 20 (1). 1165. ISSN 1471-2407

Rao, S, Sclafani, F, Eng, C et al. (18 more authors) (2020) International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology, 38 (22). pp. 2510-2518. ISSN 0732-183X

Chadi, SA, Malcomson, L, Ensor, J et al. (30 more authors) (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology and Hepatology, 3 (12). pp. 825-836. ISSN 2468-1253

Fish, R, Sanders, C, Adams, R et al. (8 more authors) (2018) A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterology and Hepatology, 3 (12). pp. 865-873. ISSN 2468-1253

Sekhar, H, Zwahlen, M, Trelle, S et al. (8 more authors) (2017) Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. The Lancet Oncology, 18 (10). pp. 1348-1359. ISSN 1470-2045

Sharma, RA, Plummer, R, Stock, JK et al. (36 more authors) (2016) Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology, 13 (10). pp. 627-642. ISSN 1759-4774

Proceedings Paper

Shiu, K-K, Seligmann, JF orcid.org/0000-0003-4379-6005, Graham, J et al. (15 more authors) (2022) NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumor mutation burden for high-risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer. In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting I, 03-07 Jun 2022, Chicago, USA. American Society of Clinical Oncology .

Gollins, S, Sebag-Montefiore, D, Adams, R et al. (9 more authors) (2015) A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL, USA. American Society of Clinical Oncology .

This list was generated on Sun Mar 24 17:05:09 2024 GMT.